ログイン

Glycosides 2

Glycosides 2
72問 • 2年前
  • Quinn Karylle Fuentes
  • 通報

    問題一覧

  • 1

    yielding hydrocyanic acid as one of the product of hydrolysis.

    Cyanogenic glycoside.

  • 2

    Derivatives are mandelonitrile

    Cyanogenic glycosides.

  • 3

    Cyanogenic glycosides represented by amygdalin which is found in?

    Almonds, Kernels, cherries, peaches.

  • 4

    Rosaceae and also prunasin occurs in?

    Prunus serotina.

  • 5

    Both amygdalin and prunasin yield R- mandelonitrile as the aglycone. (T/F)

    True.

  • 6

    S-mandelonitrile as its aglycone.

    Sambucua nigra liberates.

  • 7

    What test used to detect the cyanogenic glycosides.

    Guignard test.

  • 8

    An enzyme obtain from almond kernels consust of a mixture of two enzyme.

    Emulsin.

  • 9

    What do you call the first step of hydrolysis

    Amygalase.

  • 10

    What do you call the second step of hydrolysis

    Prunase.

  • 11

    Cyanogenic glycosides used as

    Flavoring agent, Anti cancer.

  • 12

    Possiblity yo cintrol of stickle cell anemia

    Cyanogenic glycosides.

  • 13

    Wild cherry also know as?

    Prunus virgina.

  • 14

    A classical name of plum tree.

    Prunus

  • 15

    Means late or backwards referring to the time of flowering and fruiting of the species

    Serotina.

  • 16

    What are the uses of wild cherry

    Flavored vehicle, Sedative expectorant.

  • 17

    A compound formed by prtial hydrolysis of amygdalin.

    Prunasin.

  • 18

    The yield of hydrocyanic acid varies from 0.23-0.32% in the inner bark 0.03% in trunk bark and varies even in the bark of same thickness from the same tree.

    Wild cherry.

  • 19

    sold in health - food stores as a source of laetrile mandelonitrile B-glucoroside or amygdalin which exist to the. extent about 3%

    Apricot pits.

  • 20

    The FDA banned laetrile from interstate commerce in 1971 however a number if states have sinced declared that interstate production of sale are legal

    Apricot pits.

  • 21

    Also known as prunus virginia and wild black cherry trees

    Wild cherry.

  • 22

    a classic name of plum tree

    Prunus.

  • 23

    late or backward, referring to the time of flowering and fruiting of the species.

    Serotina.

  • 24

    Sold in “health- food” stores as a source of laetrille ( - ) -mandelonitrile ß- glucuronoside or amygdalin, which exist to the extent about 3%

    Apritoct pits.

  • 25

    The seeds of several mustard family plants contain glycosides, the aglycones of which are isothiocyanates. (T/F)

    True.

  • 26

    What are the brassicaceae includes

    Oilseed, Condiments, Vegetables

  • 27

    from black mustard

    Sinigrin.

  • 28

    from white mustard

    Sinalbin.

  • 29

    from rapeseed

    Gluconapin.

  • 30

    Black mustard Also called brown mustard or sinapis nigra

    Mustard.

  • 31

    principal constituent, which accompanied by the enzyme myrosinase

    Sinigrin.

  • 32

    product in the hydrolysis of black mustard, it is volatile It is commonly called Volatile Mustard oil

    Allyl isothiocyanate.

  • 33

    White mustard also called as

    Sinapis alba.

  • 34

    Sinalbin which upon hydrolysis yield p-hydroxybenzyl isothiocyanate (acrinyl isothiocyanate), a pungent tasting but almost odorless oil

    Glucoside.

  • 35

    also possess antihyperlipidemic activity and enhance blood fibrinolytic activity and inhibits platelet aggregation

    Garlic.

  • 36

    aglycones are generally termed flavonoids (T/F)

    True.

  • 37

    Flavonoids appear yellow pigments in higher plants (T/F)

    True.

  • 38

    They have been used in the treatment of various conditions characterized by capillary bleeding and increased capillary fragility

    Flavonoids glycosides.

  • 39

    a glycoside that is also associated with salicin in the barks of salicaceae

    Populin.

  • 40

    Its action closely resembles that of salicylic acid, and it is probably oxidized to salicylic acid in the human system.

    Alcohol glycoside.

  • 41

    is a drug that has an aldehyde aglycone as its chief constituent

    Vanilla

  • 42

    s a drug that has an aldehyde aglycone as its chief constituent (T/F)

    True.

  • 43

    The cured, full grown unripe fruit of vanilla planifolia Andres often known in commerce as mexican or bourbon vanilla

    Vanilla.

  • 44

    hydrolyzed to glucose and vanillic alcohol, which in turn oxidized to vanillic aldehyde (vanillin)

    Glucovanillic alcohol.

  • 45

    the principal flavoring constituent

    Vanillin.

  • 46

    hydrolyzed by the enzyme during the curing process into glucose and vanillin

    Gluvovanillin.

  • 47

    Two third as long shape vanillin crystals posses a coumarin like odor.

    Bourbon vanilla.

  • 48

    is a reddish brown in color and about as long as the Mexican variety but sharply attenuated and twisted in lower portion

    Tahiti vanilla.

  • 49

    the odor is somewhat unpleasant and the variety is less suitable for flavoring

    Tahiti vanilla.

  • 50

    Rwpresent the more mature fruits in which dehiscence has taken place they cut into short lengths

    Vanilla splits or cuts.

  • 51

    is a 4-hydroxy-3-methoxybenzaldehyde or methyl protocatechuic aldehyde

    Vanillin.

  • 52

    a glycoside present in the cambium sap of pine trees

    Coniferin.

  • 53

    phenol present in clove oil

    Eugenol.

  • 54

    a by-product of the bulb industry Most of the vanillin in commerce is made from lignin

    Lignin.

  • 55

    a synthetic analog of vanillin is also used as flavoring agent

    Ethyl vanillin.

  • 56

    The aglycone groups of many of the naturally occurring glycosides are phenolic in character

    Phenol glycosides.

  • 57

    found in Arctostaphylos uva-ursi, chimaphila and other ericaceous drugs yields hydroquinone and glucose upon hydrolysis

    Arbutin.

  • 58

    which occurs in various citrus fruits, maybe classified as phenolic glycoside

    Hesperidin.

  • 59

    found in the root bark of rosaceous plants

    Phloridzin.

  • 60

    is the dried leaf of Arctostaphylos uva-ursi

    Bearberry.

  • 61

    Coumarin and tonka beans, coumarin containing seeds of Dipteryx odorata and Dipteryx oppositifolia were formerly used pharmaceutically as flavoring agent

    Lactone glycosides.

  • 62

    The anti- spasmodic activity of the barks of Viburnum prunifolium and V. opulus (true camp tree) (Fam. Caprifoliaceae) has been attributed to scopoletin (6 methoxy-7-hydroxycoumarin) and other coumarins

    Lactone glycoside.

  • 63

    sweet clover

    Melilotus Albus Mediscus

  • 64

    sweet vernal grass

    Anthoxanthum odoratum

  • 65

    sweet scented bedstraw

    Galium triflorum Michaux

  • 66

    Red clover

    Trifolium prantense

  • 67

    obtained originally from the improperly cured leaves and flowering tops of Melilotus officinalis

    Dicoumarol.

  • 68

    Cantharides, Spanish flies, Russian flies or blistering flies consist of the dried insect, (Cantharis vesicatoria Linne' De Geer Fam. Meloidae)

    Cantharides.

  • 69

    is the lactone anhydride of cantharidic acid. In addition, about 12% of fat is associated with the cantharidin in the soft body tissues of the insect.

    Cantharidin.

  • 70

    are photosensitizing coumarins that occur in a number of plant families,

    Psoralens.

  • 71

    a constituent of the cremocarps of Ammi majus Linne' (Fam. Umbelliferae) is used to facilitate the repigmentation of idiopathic vitiligo (leukoderma) and for control of symptomatic control of severe, disabling psoriasis

    Xanthotoxin.

  • 72

    A synthetic furocoumarin, is available for use in the treatment of vitiligo

    Trioxsalen.

  • Cell structure.

    Cell structure.

    Quinn Karylle Fuentes · 28問 · 2年前

    Cell structure.

    Cell structure.

    28問 • 2年前
    Quinn Karylle Fuentes

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    Quinn Karylle Fuentes · 29問 · 2年前

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    29問 • 2年前
    Quinn Karylle Fuentes

    MW

    MW

    Quinn Karylle Fuentes · 45問 · 2年前

    MW

    MW

    45問 • 2年前
    Quinn Karylle Fuentes

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    Quinn Karylle Fuentes · 38問 · 2年前

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    38問 • 2年前
    Quinn Karylle Fuentes

    Density and specific gravity

    Density and specific gravity

    Quinn Karylle Fuentes · 34問 · 2年前

    Density and specific gravity

    Density and specific gravity

    34問 • 2年前
    Quinn Karylle Fuentes

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    Quinn Karylle Fuentes · 18問 · 2年前

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    18問 • 2年前
    Quinn Karylle Fuentes

    Microbial growth

    Microbial growth

    Quinn Karylle Fuentes · 63問 · 2年前

    Microbial growth

    Microbial growth

    63問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 61問 · 2年前

    Introduction.

    Introduction.

    61問 • 2年前
    Quinn Karylle Fuentes

    Microbial control.

    Microbial control.

    Quinn Karylle Fuentes · 97問 · 2年前

    Microbial control.

    Microbial control.

    97問 • 2年前
    Quinn Karylle Fuentes

    States of matter

    States of matter

    Quinn Karylle Fuentes · 100問 · 2年前

    States of matter

    States of matter

    100問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 86問 · 2年前

    Introduction.

    Introduction.

    86問 • 2年前
    Quinn Karylle Fuentes

    Drug development.

    Drug development.

    Quinn Karylle Fuentes · 77問 · 2年前

    Drug development.

    Drug development.

    77問 • 2年前
    Quinn Karylle Fuentes

    CGMP

    CGMP

    Quinn Karylle Fuentes · 9問 · 2年前

    CGMP

    CGMP

    9問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    Quinn Karylle Fuentes · 24問 · 2年前

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    24問 • 2年前
    Quinn Karylle Fuentes

    Powdered & granules

    Powdered & granules

    Quinn Karylle Fuentes · 43問 · 2年前

    Powdered & granules

    Powdered & granules

    43問 • 2年前
    Quinn Karylle Fuentes

    Capsule.

    Capsule.

    Quinn Karylle Fuentes · 24問 · 2年前

    Capsule.

    Capsule.

    24問 • 2年前
    Quinn Karylle Fuentes

    Tablets.

    Tablets.

    Quinn Karylle Fuentes · 23問 · 2年前

    Tablets.

    Tablets.

    23問 • 2年前
    Quinn Karylle Fuentes

    Calculatiom of dose

    Calculatiom of dose

    Quinn Karylle Fuentes · 3回閲覧 · 66問 · 2年前

    Calculatiom of dose

    Calculatiom of dose

    3回閲覧 • 66問 • 2年前
    Quinn Karylle Fuentes

    Postlab 5&6

    Postlab 5&6

    Quinn Karylle Fuentes · 29問 · 2年前

    Postlab 5&6

    Postlab 5&6

    29問 • 2年前
    Quinn Karylle Fuentes

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    Quinn Karylle Fuentes · 33問 · 2年前

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    33問 • 2年前
    Quinn Karylle Fuentes

    SEMI SOLID

    SEMI SOLID

    Quinn Karylle Fuentes · 69問 · 2年前

    SEMI SOLID

    SEMI SOLID

    69問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology

    Basic immunology

    Quinn Karylle Fuentes · 60問 · 2年前

    Basic immunology

    Basic immunology

    60問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology (2)

    Basic immunology (2)

    Quinn Karylle Fuentes · 62問 · 2年前

    Basic immunology (2)

    Basic immunology (2)

    62問 • 2年前
    Quinn Karylle Fuentes

    Transdermal

    Transdermal

    Quinn Karylle Fuentes · 44問 · 2年前

    Transdermal

    Transdermal

    44問 • 2年前
    Quinn Karylle Fuentes

    Distribution.

    Distribution.

    Quinn Karylle Fuentes · 43問 · 2年前

    Distribution.

    Distribution.

    43問 • 2年前
    Quinn Karylle Fuentes

    Infectious disease.

    Infectious disease.

    Quinn Karylle Fuentes · 65問 · 2年前

    Infectious disease.

    Infectious disease.

    65問 • 2年前
    Quinn Karylle Fuentes

    Infectious diseases (2)

    Infectious diseases (2)

    Quinn Karylle Fuentes · 79問 · 2年前

    Infectious diseases (2)

    Infectious diseases (2)

    79問 • 2年前
    Quinn Karylle Fuentes

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    Quinn Karylle Fuentes · 35問 · 2年前

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    Quinn Karylle Fuentes · 35問 · 2年前

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic ( Compressed)

    All topic ( Compressed)

    Quinn Karylle Fuentes · 30問 · 2年前

    All topic ( Compressed)

    All topic ( Compressed)

    30問 • 2年前
    Quinn Karylle Fuentes

    All topics (compressed)

    All topics (compressed)

    Quinn Karylle Fuentes · 13問 · 2年前

    All topics (compressed)

    All topics (compressed)

    13問 • 2年前
    Quinn Karylle Fuentes

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    Quinn Karylle Fuentes · 28問 · 2年前

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    28問 • 2年前
    Quinn Karylle Fuentes

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    Quinn Karylle Fuentes · 16問 · 2年前

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    16問 • 2年前
    Quinn Karylle Fuentes

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    Quinn Karylle Fuentes · 26問 · 2年前

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    26問 • 2年前
    Quinn Karylle Fuentes

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    Quinn Karylle Fuentes · 23問 · 2年前

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    23問 • 2年前
    Quinn Karylle Fuentes

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Quinn Karylle Fuentes · 35問 · 2年前

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    35問 • 2年前
    Quinn Karylle Fuentes

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    Quinn Karylle Fuentes · 20問 · 2年前

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    20問 • 2年前
    Quinn Karylle Fuentes

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    Quinn Karylle Fuentes · 33問 · 2年前

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    33問 • 2年前
    Quinn Karylle Fuentes

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    Quinn Karylle Fuentes · 37問 · 2年前

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    37問 • 2年前
    Quinn Karylle Fuentes

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    Quinn Karylle Fuentes · 23問 · 2年前

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    23問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae

    Enterobacteriaceae

    Quinn Karylle Fuentes · 35問 · 2年前

    Enterobacteriaceae

    Enterobacteriaceae

    35問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae.

    Enterobacteriaceae.

    Quinn Karylle Fuentes · 28問 · 2年前

    Enterobacteriaceae.

    Enterobacteriaceae.

    28問 • 2年前
    Quinn Karylle Fuentes

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    Quinn Karylle Fuentes · 31問 · 2年前

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    31問 • 2年前
    Quinn Karylle Fuentes

    Liquid dosage form

    Liquid dosage form

    Quinn Karylle Fuentes · 12問 · 2年前

    Liquid dosage form

    Liquid dosage form

    12問 • 2年前
    Quinn Karylle Fuentes

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    Quinn Karylle Fuentes · 44問 · 2年前

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    44問 • 2年前
    Quinn Karylle Fuentes

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    Quinn Karylle Fuentes · 22問 · 2年前

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    22問 • 2年前
    Quinn Karylle Fuentes

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    Quinn Karylle Fuentes · 40問 · 2年前

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    40問 • 2年前
    Quinn Karylle Fuentes

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    Quinn Karylle Fuentes · 29問 · 2年前

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    29問 • 2年前
    Quinn Karylle Fuentes

    Drug incompatibilities.

    Drug incompatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug incompatibilities.

    Drug incompatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    Drug compatibilities.

    Drug compatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug compatibilities.

    Drug compatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 35問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    35問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 30問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    30問 • 2年前
    Quinn Karylle Fuentes

    SUSPENSION.

    SUSPENSION.

    Quinn Karylle Fuentes · 45問 · 2年前

    SUSPENSION.

    SUSPENSION.

    45問 • 2年前
    Quinn Karylle Fuentes

    Colloidal.

    Colloidal.

    Quinn Karylle Fuentes · 40問 · 2年前

    Colloidal.

    Colloidal.

    40問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    Quinn Karylle Fuentes · 38問 · 2年前

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    38問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY.

    BACTERIOLOGY.

    Quinn Karylle Fuentes · 44問 · 2年前

    BACTERIOLOGY.

    BACTERIOLOGY.

    44問 • 2年前
    Quinn Karylle Fuentes

    Emulsion.

    Emulsion.

    Quinn Karylle Fuentes · 32問 · 2年前

    Emulsion.

    Emulsion.

    32問 • 2年前
    Quinn Karylle Fuentes

    EMULSION

    EMULSION

    Quinn Karylle Fuentes · 42問 · 2年前

    EMULSION

    EMULSION

    42問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    Quinn Karylle Fuentes · 36問 · 2年前

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    36問 • 2年前
    Quinn Karylle Fuentes

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    Quinn Karylle Fuentes · 33問 · 2年前

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    33問 • 2年前
    Quinn Karylle Fuentes

    Mycology.

    Mycology.

    Quinn Karylle Fuentes · 30問 · 2年前

    Mycology.

    Mycology.

    30問 • 2年前
    Quinn Karylle Fuentes

    Mycology 2.0

    Mycology 2.0

    Quinn Karylle Fuentes · 34問 · 2年前

    Mycology 2.0

    Mycology 2.0

    34問 • 2年前
    Quinn Karylle Fuentes

    m

    m

    Quinn Karylle Fuentes · 15問 · 2年前

    m

    m

    15問 • 2年前
    Quinn Karylle Fuentes

    ppr

    ppr

    Quinn Karylle Fuentes · 25問 · 2年前

    ppr

    ppr

    25問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    Quinn Karylle Fuentes · 20問 · 2年前

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    20問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    Quinn Karylle Fuentes · 86問 · 2年前

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    86問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    Quinn Karylle Fuentes · 100問 · 2年前

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    100問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    Quinn Karylle Fuentes · 19問 · 2年前

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    19問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 17問 · 2年前

    Introduction.

    Introduction.

    17問 • 2年前
    Quinn Karylle Fuentes

    Introduction of biochemistry

    Introduction of biochemistry

    Quinn Karylle Fuentes · 76問 · 2年前

    Introduction of biochemistry

    Introduction of biochemistry

    76問 • 2年前
    Quinn Karylle Fuentes

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    Quinn Karylle Fuentes · 56問 · 2年前

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    56問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 75問 · 2年前

    Carbohydrates

    Carbohydrates

    75問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates 1.1

    Carbohydrates 1.1

    Quinn Karylle Fuentes · 31問 · 2年前

    Carbohydrates 1.1

    Carbohydrates 1.1

    31問 • 2年前
    Quinn Karylle Fuentes

    Detect and quality variation.

    Detect and quality variation.

    Quinn Karylle Fuentes · 56問 · 2年前

    Detect and quality variation.

    Detect and quality variation.

    56問 • 2年前
    Quinn Karylle Fuentes

    INTRODUCTION

    INTRODUCTION

    Quinn Karylle Fuentes · 98問 · 2年前

    INTRODUCTION

    INTRODUCTION

    98問 • 2年前
    Quinn Karylle Fuentes

    lab (1-2)

    lab (1-2)

    Quinn Karylle Fuentes · 15問 · 2年前

    lab (1-2)

    lab (1-2)

    15問 • 2年前
    Quinn Karylle Fuentes

    lab 1-2

    lab 1-2

    Quinn Karylle Fuentes · 14問 · 2年前

    lab 1-2

    lab 1-2

    14問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    Quinn Karylle Fuentes · 45問 · 2年前

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    45問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    Quinn Karylle Fuentes · 35問 · 2年前

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    35問 • 2年前
    Quinn Karylle Fuentes

    Unit 3.

    Unit 3.

    Quinn Karylle Fuentes · 39問 · 2年前

    Unit 3.

    Unit 3.

    39問 • 2年前
    Quinn Karylle Fuentes

    Histamin and kinins

    Histamin and kinins

    Quinn Karylle Fuentes · 70問 · 2年前

    Histamin and kinins

    Histamin and kinins

    70問 • 2年前
    Quinn Karylle Fuentes

    PUD.

    PUD.

    Quinn Karylle Fuentes · 45問 · 2年前

    PUD.

    PUD.

    45問 • 2年前
    Quinn Karylle Fuentes

    ..

    ..

    Quinn Karylle Fuentes · 61問 · 2年前

    ..

    ..

    61問 • 2年前
    Quinn Karylle Fuentes

    Lipids.

    Lipids.

    Quinn Karylle Fuentes · 67問 · 2年前

    Lipids.

    Lipids.

    67問 • 2年前
    Quinn Karylle Fuentes

    lipids.

    lipids.

    Quinn Karylle Fuentes · 71問 · 2年前

    lipids.

    lipids.

    71問 • 2年前
    Quinn Karylle Fuentes

    LAB ✨

    LAB ✨

    Quinn Karylle Fuentes · 93問 · 2年前

    LAB ✨

    LAB ✨

    93問 • 2年前
    Quinn Karylle Fuentes

    Drug discovery.

    Drug discovery.

    Quinn Karylle Fuentes · 87問 · 2年前

    Drug discovery.

    Drug discovery.

    87問 • 2年前
    Quinn Karylle Fuentes

    disease of lipids.

    disease of lipids.

    Quinn Karylle Fuentes · 13問 · 2年前

    disease of lipids.

    disease of lipids.

    13問 • 2年前
    Quinn Karylle Fuentes

    Intro (identify structure)

    Intro (identify structure)

    Quinn Karylle Fuentes · 57問 · 2年前

    Intro (identify structure)

    Intro (identify structure)

    57問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 98問 · 2年前

    Carbohydrates

    Carbohydrates

    98問 • 2年前
    Quinn Karylle Fuentes

    Dynamic.

    Dynamic.

    Quinn Karylle Fuentes · 96問 · 2年前

    Dynamic.

    Dynamic.

    96問 • 2年前
    Quinn Karylle Fuentes

    Unit 1

    Unit 1

    Quinn Karylle Fuentes · 32問 · 2年前

    Unit 1

    Unit 1

    32問 • 2年前
    Quinn Karylle Fuentes

    問題一覧

  • 1

    yielding hydrocyanic acid as one of the product of hydrolysis.

    Cyanogenic glycoside.

  • 2

    Derivatives are mandelonitrile

    Cyanogenic glycosides.

  • 3

    Cyanogenic glycosides represented by amygdalin which is found in?

    Almonds, Kernels, cherries, peaches.

  • 4

    Rosaceae and also prunasin occurs in?

    Prunus serotina.

  • 5

    Both amygdalin and prunasin yield R- mandelonitrile as the aglycone. (T/F)

    True.

  • 6

    S-mandelonitrile as its aglycone.

    Sambucua nigra liberates.

  • 7

    What test used to detect the cyanogenic glycosides.

    Guignard test.

  • 8

    An enzyme obtain from almond kernels consust of a mixture of two enzyme.

    Emulsin.

  • 9

    What do you call the first step of hydrolysis

    Amygalase.

  • 10

    What do you call the second step of hydrolysis

    Prunase.

  • 11

    Cyanogenic glycosides used as

    Flavoring agent, Anti cancer.

  • 12

    Possiblity yo cintrol of stickle cell anemia

    Cyanogenic glycosides.

  • 13

    Wild cherry also know as?

    Prunus virgina.

  • 14

    A classical name of plum tree.

    Prunus

  • 15

    Means late or backwards referring to the time of flowering and fruiting of the species

    Serotina.

  • 16

    What are the uses of wild cherry

    Flavored vehicle, Sedative expectorant.

  • 17

    A compound formed by prtial hydrolysis of amygdalin.

    Prunasin.

  • 18

    The yield of hydrocyanic acid varies from 0.23-0.32% in the inner bark 0.03% in trunk bark and varies even in the bark of same thickness from the same tree.

    Wild cherry.

  • 19

    sold in health - food stores as a source of laetrile mandelonitrile B-glucoroside or amygdalin which exist to the. extent about 3%

    Apricot pits.

  • 20

    The FDA banned laetrile from interstate commerce in 1971 however a number if states have sinced declared that interstate production of sale are legal

    Apricot pits.

  • 21

    Also known as prunus virginia and wild black cherry trees

    Wild cherry.

  • 22

    a classic name of plum tree

    Prunus.

  • 23

    late or backward, referring to the time of flowering and fruiting of the species.

    Serotina.

  • 24

    Sold in “health- food” stores as a source of laetrille ( - ) -mandelonitrile ß- glucuronoside or amygdalin, which exist to the extent about 3%

    Apritoct pits.

  • 25

    The seeds of several mustard family plants contain glycosides, the aglycones of which are isothiocyanates. (T/F)

    True.

  • 26

    What are the brassicaceae includes

    Oilseed, Condiments, Vegetables

  • 27

    from black mustard

    Sinigrin.

  • 28

    from white mustard

    Sinalbin.

  • 29

    from rapeseed

    Gluconapin.

  • 30

    Black mustard Also called brown mustard or sinapis nigra

    Mustard.

  • 31

    principal constituent, which accompanied by the enzyme myrosinase

    Sinigrin.

  • 32

    product in the hydrolysis of black mustard, it is volatile It is commonly called Volatile Mustard oil

    Allyl isothiocyanate.

  • 33

    White mustard also called as

    Sinapis alba.

  • 34

    Sinalbin which upon hydrolysis yield p-hydroxybenzyl isothiocyanate (acrinyl isothiocyanate), a pungent tasting but almost odorless oil

    Glucoside.

  • 35

    also possess antihyperlipidemic activity and enhance blood fibrinolytic activity and inhibits platelet aggregation

    Garlic.

  • 36

    aglycones are generally termed flavonoids (T/F)

    True.

  • 37

    Flavonoids appear yellow pigments in higher plants (T/F)

    True.

  • 38

    They have been used in the treatment of various conditions characterized by capillary bleeding and increased capillary fragility

    Flavonoids glycosides.

  • 39

    a glycoside that is also associated with salicin in the barks of salicaceae

    Populin.

  • 40

    Its action closely resembles that of salicylic acid, and it is probably oxidized to salicylic acid in the human system.

    Alcohol glycoside.

  • 41

    is a drug that has an aldehyde aglycone as its chief constituent

    Vanilla

  • 42

    s a drug that has an aldehyde aglycone as its chief constituent (T/F)

    True.

  • 43

    The cured, full grown unripe fruit of vanilla planifolia Andres often known in commerce as mexican or bourbon vanilla

    Vanilla.

  • 44

    hydrolyzed to glucose and vanillic alcohol, which in turn oxidized to vanillic aldehyde (vanillin)

    Glucovanillic alcohol.

  • 45

    the principal flavoring constituent

    Vanillin.

  • 46

    hydrolyzed by the enzyme during the curing process into glucose and vanillin

    Gluvovanillin.

  • 47

    Two third as long shape vanillin crystals posses a coumarin like odor.

    Bourbon vanilla.

  • 48

    is a reddish brown in color and about as long as the Mexican variety but sharply attenuated and twisted in lower portion

    Tahiti vanilla.

  • 49

    the odor is somewhat unpleasant and the variety is less suitable for flavoring

    Tahiti vanilla.

  • 50

    Rwpresent the more mature fruits in which dehiscence has taken place they cut into short lengths

    Vanilla splits or cuts.

  • 51

    is a 4-hydroxy-3-methoxybenzaldehyde or methyl protocatechuic aldehyde

    Vanillin.

  • 52

    a glycoside present in the cambium sap of pine trees

    Coniferin.

  • 53

    phenol present in clove oil

    Eugenol.

  • 54

    a by-product of the bulb industry Most of the vanillin in commerce is made from lignin

    Lignin.

  • 55

    a synthetic analog of vanillin is also used as flavoring agent

    Ethyl vanillin.

  • 56

    The aglycone groups of many of the naturally occurring glycosides are phenolic in character

    Phenol glycosides.

  • 57

    found in Arctostaphylos uva-ursi, chimaphila and other ericaceous drugs yields hydroquinone and glucose upon hydrolysis

    Arbutin.

  • 58

    which occurs in various citrus fruits, maybe classified as phenolic glycoside

    Hesperidin.

  • 59

    found in the root bark of rosaceous plants

    Phloridzin.

  • 60

    is the dried leaf of Arctostaphylos uva-ursi

    Bearberry.

  • 61

    Coumarin and tonka beans, coumarin containing seeds of Dipteryx odorata and Dipteryx oppositifolia were formerly used pharmaceutically as flavoring agent

    Lactone glycosides.

  • 62

    The anti- spasmodic activity of the barks of Viburnum prunifolium and V. opulus (true camp tree) (Fam. Caprifoliaceae) has been attributed to scopoletin (6 methoxy-7-hydroxycoumarin) and other coumarins

    Lactone glycoside.

  • 63

    sweet clover

    Melilotus Albus Mediscus

  • 64

    sweet vernal grass

    Anthoxanthum odoratum

  • 65

    sweet scented bedstraw

    Galium triflorum Michaux

  • 66

    Red clover

    Trifolium prantense

  • 67

    obtained originally from the improperly cured leaves and flowering tops of Melilotus officinalis

    Dicoumarol.

  • 68

    Cantharides, Spanish flies, Russian flies or blistering flies consist of the dried insect, (Cantharis vesicatoria Linne' De Geer Fam. Meloidae)

    Cantharides.

  • 69

    is the lactone anhydride of cantharidic acid. In addition, about 12% of fat is associated with the cantharidin in the soft body tissues of the insect.

    Cantharidin.

  • 70

    are photosensitizing coumarins that occur in a number of plant families,

    Psoralens.

  • 71

    a constituent of the cremocarps of Ammi majus Linne' (Fam. Umbelliferae) is used to facilitate the repigmentation of idiopathic vitiligo (leukoderma) and for control of symptomatic control of severe, disabling psoriasis

    Xanthotoxin.

  • 72

    A synthetic furocoumarin, is available for use in the treatment of vitiligo

    Trioxsalen.